Centrum 7/6  banner

Camber Pharmaceuticals recognized by HDA

Print Friendly, PDF & Email

PISCATAWAY, N.J. —Camber announced that the company was awarded the Second Merit Finalist for Best Overall Generic Pharmaceutical Product Manufacturer with Less Than $100 Million in Sales to Healthcare Distributors at the 2019 Business and Leadership Conference in Orlando, Florida.  HDA’s distributor members vote on this award.

From the left to right: John Gray, president and CEO of HDA, Crystal Mechler, director of national accounts of Camber Pharmaceuticals, Stu Messinger, director of national accounts of Camber Pharmaceuticals and Greg Drew, president of Value Drug Company and chairman of HDA board of directors.

Since 1959, HDA’s Distribution Industry Award for Notable Achievements in Healthcare (DIANA) has been among the pharmaceutical distribution industry’s most prestigious honors. The awards are presented annually to eligible HDA manufacturer member companies.

The DIANA recognizes pharmaceutical and consumer product manufacturers for developing innovative new product introductions and promotions for the healthcare distribution industry. Manufacturers also are recognized for continually fostering strong trading partner relationships with the Alliance’s distributor members by creating exceptional business practices that advance trade relations and benefit the entire healthcare supply chain.

Winners, selected by HDA distributor members, serve as a model for leadership and innovation in the healthcare marketplace and become part of the tradition of excellence that the DIANA has fostered for more than a half-century.



Comments are closed.